Kimberly Duffy has been with Merck since 1988, her entire career in the vaccine manufacturing field.  Kim has held positions in Vaccine Manufacturing, Quality Control, Laboratory Operations, and Regulatory Affairs.  Kim joined the Regulatory CMC group in 2007 and has led the organization responsible for global registrations and post-approval changes for a variety of vaccines; specializing in US, Europe, Japan, and China.  Kim is currently leading the CMC regulatory group responsible for INDs/CTAs, Initial Registrations, and Post-Approval changes of Merck’s viral vaccine portfolio.